UniProt ID | RNF11_HUMAN | |
---|---|---|
UniProt AC | Q9Y3C5 | |
Protein Name | RING finger protein 11 | |
Gene Name | RNF11 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 154 | |
Subcellular Localization | Early endosome. Recycling endosome. Cytoplasm. Nucleus. Predominantly cytoplasmic, when unphosphorylated, and nuclear, when phosphorylated by PKB/AKT1. | |
Protein Description | Essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. Promotes the association of TNFAIP3 to RIPK1 after TNF stimulation. TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Recruits STAMBP to the E3 ubiquitin-ligase SMURF2 for ubiquitination, leading to its degradation by the 26S proteasome.. | |
Protein Sequence | MGNCLKSPTSDDISLLHESQSDRASFGEGTEPDQEPPPPYQEQVPVPVYHPTPSQTRLATQLTEEEQIRIAQRIGLIQHLPKGVYDPGRDGSEKKIRECVICMMDFVYGDPIRFLPCMHIYHLDCIDDWLMRSFTCPSCMEPVDAALLSSYETN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGNCLKSPT ------CCCCCCCCC | 33.29 | 20676133 | |
2 | N-myristoyl glycine | ------MGNCLKSPT ------CCCCCCCCC | 33.29 | - | |
4 | S-palmitoylation | ----MGNCLKSPTSD ----CCCCCCCCCCC | 4.13 | 20676133 | |
4 | S-nitrosylation | ----MGNCLKSPTSD ----CCCCCCCCCCC | 4.13 | 24105792 | |
7 | Phosphorylation | -MGNCLKSPTSDDIS -CCCCCCCCCCCCCH | 22.06 | 30266825 | |
9 | Phosphorylation | GNCLKSPTSDDISLL CCCCCCCCCCCCHHH | 52.45 | 30266825 | |
10 | Phosphorylation | NCLKSPTSDDISLLH CCCCCCCCCCCHHHC | 36.35 | 30266825 | |
14 | Phosphorylation | SPTSDDISLLHESQS CCCCCCCHHHCHHHC | 31.69 | 30266825 | |
19 | Phosphorylation | DISLLHESQSDRASF CCHHHCHHHCCHHCC | 25.00 | 30266825 | |
21 | Phosphorylation | SLLHESQSDRASFGE HHHCHHHCCHHCCCC | 38.04 | 30266825 | |
25 | Phosphorylation | ESQSDRASFGEGTEP HHHCCHHCCCCCCCC | 34.38 | 23663014 | |
30 | Phosphorylation | RASFGEGTEPDQEPP HHCCCCCCCCCCCCC | 39.79 | 23663014 | |
40 | Phosphorylation | DQEPPPPYQEQVPVP CCCCCCCCCCCCCCC | 30.38 | 28060719 | |
49 | Phosphorylation | EQVPVPVYHPTPSQT CCCCCCCCCCCHHHH | 8.94 | 30576142 | |
52 | Phosphorylation | PVPVYHPTPSQTRLA CCCCCCCCHHHHCHH | 23.43 | 28060719 | |
54 | Phosphorylation | PVYHPTPSQTRLATQ CCCCCCHHHHCHHHC | 46.81 | 28060719 | |
56 | Phosphorylation | YHPTPSQTRLATQLT CCCCHHHHCHHHCCC | 31.80 | 30576142 | |
82 | Ubiquitination | GLIQHLPKGVYDPGR CHHHHCCCCCCCCCC | 68.33 | 33845483 | |
135 | Phosphorylation | DWLMRSFTCPSCMEP HHHHHHCCCCCCCCC | 25.42 | 16123141 | |
151 | Phosphorylation | DAALLSSYETN---- CHHHHHHHCCC---- | 24.32 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
135 | T | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
135 | T | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:19953087 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF2 | Q9HAU4 | PMID:14562029 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:18724389 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RNF11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RNF11_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Myristoylation | |
Reference | PubMed |
"Strategy for comprehensive identification of human N-myristoylatedproteins using an insect cell-free protein synthesis system."; Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,Tsunasawa S., Utsumi T.; Proteomics 10:1780-1793(2010). Cited for: MYRISTOYLATION AT GLY-2. | |
Phosphorylation | |
Reference | PubMed |
"Molecular characterization of ring finger protein 11."; Connor M.K., Azmi P.B., Subramaniam V., Li H., Seth A.K.; Mol. Cancer Res. 3:453-461(2005). Cited for: PROTEIN SEQUENCE OF 70-113 AND 132-154, PHOSPHORYLATION AT THR-135,SUBCELLULAR LOCATION, INTERACTION WITH 14-3-3, AND MUTAGENESIS OFTHR-135. |